Literature DB >> 18349798

Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis.

Wei-Ping Chen1, Miharu Samuraki, Daisuke Yanase, Keisuke Shima, Nozomi Takeda, Kenjiro Ono, Mitsuhiro Yoshita, Shintaro Nishimura, Masahito Yamada, Ichiro Matsunari.   

Abstract

OBJECTIVE: To investigate the relationship between the sample size for a normal database (NDB) and diagnostic performance of FDG PET using three-dimensional stereotactic surface projection for the detection of Alzheimer's disease.
METHODS: We generated nine NDB sets consisting of 4, 6, 8, 10, 20, 30, 40, 50 and 60 normal subjects. In order to assess the diagnostic performance using these NDBs to distinguish Alzheimer's disease patients from normal subjects, we recruited 52 patients with probable Alzheimer's disease (25 males, 27 females; mean age, 66.8+/-8.1 years) and 50 normal subjects (24 males, 26 females; mean age, 65.7+/-9.4 years). A receiver operating characteristic (ROC) analysis was performed for comparison of diagnostic accuracy among NDB sets.
RESULTS: Small NDBs (n< or =10) yielded poor quality of mean and SD images as compared with large NDBs (n> or =20). The ROC curves of the smaller group varied inconsistently, whereas those of the larger group were nearly superimposable. The area under the ROC curve (AUC) of the NDBs with sample size 6 (0.911) or 8 (0.929) was significantly smaller than that of the largest NDB (n=60, 0.956). The AUCs of the larger group did not fall below 0.950, whereas AUCs of the smaller subgroup never exceeded 0.950.
CONCLUSIONS: Our data indicate that the sample size for an NDB affects the diagnostic performance of FDG PET using automated statistical approach, and that inclusion of at least 10 subjects is recommended, and 20 seems to be preferable for generating NDBs, although even a small NDB may provide clinically relevant results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349798     DOI: 10.1097/MNM.0b013e3282f3fa76

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  7 in total

1.  Is it time to re-prioritize neuroimaging databases and digital repositories?

Authors:  John Darrell Van Horn; Arthur W Toga
Journal:  Neuroimage       Date:  2009-04-14       Impact factor: 6.556

2.  Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection.

Authors:  T Uemura; K Ishii; N Miyamoto; T Yoshikawa
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

3.  Longitudinal Partial Volume Correction in 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Studies of Alzheimer Disease.

Authors:  Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Rodney J Hicks; Terence J OʼBrien
Journal:  J Comput Assist Tomogr       Date:  2015 Jul-Aug       Impact factor: 1.826

4.  Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Authors:  Jean-Paul Soucy; Robert Bartha; Christian Bocti; Michael Borrie; Amer M Burhan; Robert Laforce; Pedro Rosa-Neto
Journal:  Alzheimers Res Ther       Date:  2013-07-08       Impact factor: 6.982

5.  Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Authors:  Daniela Perani; Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Federico Fallanca; Emilia Giovanna Vanoli; Andrea Panzacchi; Flavio Nobili; Sabina Pappatà; Alessandra Marcone; Valentina Garibotto; Isabella Castiglioni; Giuseppe Magnani; Stefano F Cappa; Luigi Gianolli
Journal:  Neuroimage Clin       Date:  2014-10-24       Impact factor: 4.881

6.  Quantitative and qualitative evaluation of hybrid iterative reconstruction, with and without noise power spectrum models: A phantom study.

Authors:  Kazuya Minamishima; Koichi Sugisawa; Yoshitake Yamada; Masahiro Jinzaki
Journal:  J Appl Clin Med Phys       Date:  2018-02-28       Impact factor: 2.102

7.  Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.

Authors:  Xueqi Chen; Yun Zhou; Rongfu Wang; Haoyin Cao; Savina Reid; Rui Gao; Dong Han
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.